Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	196.20M -5.7%
Revenue (ttm)	336.68M -1.4%
Net Income	5.02M -51.6%
EPS	0.06 -53.0%
Shares Out	81.41M
PE Ratio	40.17
Forward PE	34.43
Dividend	0.05 (2.09%)
Ex-Dividend Date	May 15, 2025

Volume	14,538
Average Volume	48,777
Open	2.370
Previous Close	2.350
Day's Range	2.370 - 2.420
52-Week Range	2.320 - 3.400
Beta	0.96
RSI	30.57
Earnings Date	Feb 27, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,426
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2025, Laboratorio Reig Jofre's revenue was 336.68 million, a decrease of -1.37% compared to the previous year's 341.37 million. Earnings were 5.02 million, a decrease of -51.64%.